Logo image of OMDA

OMADA HEALTH INC (OMDA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:OMDA - US68170A1088 - Common Stock

18.73 USD
+0.53 (+2.91%)
Last: 11/28/2025, 7:53:33 PM
18.73 USD
0 (0%)
After Hours: 11/28/2025, 7:53:33 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OMDA. OMDA was compared to 101 industry peers in the Health Care Providers & Services industry. OMDA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, OMDA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OMDA has reported negative net income.
OMDA Yearly Net Income VS EBIT VS OCF VS FCFOMDA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

OMDA has a worse Return On Assets (-22.64%) than 81.19% of its industry peers.
Looking at the Return On Equity, with a value of -29.94%, OMDA is doing worse than 68.32% of the companies in the same industry.
Industry RankSector Rank
ROA -22.64%
ROE -29.94%
ROIC N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMDA Yearly ROA, ROE, ROICOMDA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

With an excellent Gross Margin value of 62.16%, OMDA belongs to the best of the industry, outperforming 82.18% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for OMDA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMDA Yearly Profit, Operating, Gross MarginsOMDA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

OMDA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OMDA remains at a similar level compared to 1 year ago.
The debt/assets ratio for OMDA is higher compared to a year ago.
OMDA Yearly Shares OutstandingOMDA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
OMDA Yearly Total Debt VS Total AssetsOMDA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

OMDA has an Altman-Z score of 8.04. This indicates that OMDA is financially healthy and has little risk of bankruptcy at the moment.
OMDA has a better Altman-Z score (8.04) than 93.07% of its industry peers.
OMDA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.04
ROIC/WACCN/A
WACC8.94%
OMDA Yearly LT Debt VS Equity VS FCFOMDA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

OMDA has a Current Ratio of 3.64. This indicates that OMDA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OMDA (3.64) is better than 89.11% of its industry peers.
A Quick Ratio of 3.59 indicates that OMDA has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.59, OMDA belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 3.59
OMDA Yearly Current Assets VS Current LiabilitesOMDA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

OMDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.18%, which is quite impressive.
OMDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.29%.
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, OMDA will show a very strong growth in Earnings Per Share. The EPS will grow by 32.26% on average per year.
OMDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.41% yearly.
EPS Next Y49.2%
EPS Next 2Y37.99%
EPS Next 3Y32.26%
EPS Next 5YN/A
Revenue Next Year43.42%
Revenue Next 2Y31.19%
Revenue Next 3Y27.41%
Revenue Next 5YN/A

3.3 Evolution

OMDA Yearly Revenue VS EstimatesOMDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
OMDA Yearly EPS VS EstimatesOMDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OMDA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OMDA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OMDA Price Earnings VS Forward Price EarningsOMDA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMDA Per share dataOMDA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

OMDA's earnings are expected to grow with 32.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.99%
EPS Next 3Y32.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OMDA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OMADA HEALTH INC

NASDAQ:OMDA (11/28/2025, 7:53:33 PM)

After market: 18.73 0 (0%)

18.73

+0.53 (+2.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)N/A N/A
Inst Owners62.6%
Inst Owner Change23.33%
Ins Owners6.01%
Ins Owner Change100%
Market Cap1.08B
Revenue(TTM)354.16M
Net Income(TTM)-65.07M
Analysts80
Price Target29.48 (57.39%)
Short Float %5.5%
Short Ratio5.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.37%
Min EPS beat(2)5.88%
Max EPS beat(2)22.85%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.17%
Min Revenue beat(2)9.04%
Max Revenue beat(2)9.3%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.06%
PT rev (3m)4.28%
EPS NQ rev (1m)71.61%
EPS NQ rev (3m)75.56%
EPS NY rev (1m)-3.27%
EPS NY rev (3m)-33.92%
Revenue NQ rev (1m)12.42%
Revenue NQ rev (3m)15.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.04
P/FCF N/A
P/OCF N/A
P/B 4.96
P/tB 5.36
EV/EBITDA N/A
EPS(TTM)-1.17
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.15
BVpS3.78
TBVpS3.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.64%
ROE -29.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.16%
FCFM N/A
ROA(3y)-34.16%
ROA(5y)N/A
ROE(3y)-62.59%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.64
Quick Ratio 3.59
Altman-Z 8.04
F-ScoreN/A
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)69.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y49.2%
EPS Next 2Y37.99%
EPS Next 3Y32.26%
EPS Next 5YN/A
Revenue 1Y (TTM)38.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year43.42%
Revenue Next 2Y31.19%
Revenue Next 3Y27.41%
Revenue Next 5YN/A
EBIT growth 1Y33.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.57%
EBIT Next 3Y32.72%
EBIT Next 5YN/A
FCF growth 1Y27.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.28%
OCF growth 3YN/A
OCF growth 5YN/A

OMADA HEALTH INC / OMDA FAQ

What is the fundamental rating for OMDA stock?

ChartMill assigns a fundamental rating of 4 / 10 to OMDA.


What is the valuation status of OMADA HEALTH INC (OMDA) stock?

ChartMill assigns a valuation rating of 1 / 10 to OMADA HEALTH INC (OMDA). This can be considered as Overvalued.


Can you provide the profitability details for OMADA HEALTH INC?

OMADA HEALTH INC (OMDA) has a profitability rating of 1 / 10.


How financially healthy is OMADA HEALTH INC?

The financial health rating of OMADA HEALTH INC (OMDA) is 8 / 10.